Arrowpoint Investment Partners (Singapore) Pte. Ltd. — 13F Holdings & Portfolio

CIK 2032331 · latest 13F-HR filed 2026-08-13

Arrowpoint Investment Partners (Singapore) Pte. Ltd. manages $459.0M in 13F-reported U.S. long-equity assets across 129 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SMH (11.43%), C (7.17%), GS (6.82%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 82 new positions, exited 35, added to 31, and trimmed 10.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
9 STRAITS VIEW
24-08, MARINA ONE WEST TOWER
SINGAPORE 018937
Phone
(656) 031-0885
Filing Manager
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
SINGAPORE, U0
Signatory
AMY TEH
CHIEF COMPLIANCE OFFICER
Loading holdings…
AUM

$459.0M

Long-equity book

Holdings

129

Distinct positions

Period

2026-06-30

Filed 2026-08-13

Q/Q Activity

+82 / −35 / ↑31 / ↓10

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • ALPHABET INC$3.4M +38.0%
  • ELI LILLY & CO$2.6M +651.7%
  • MADRIGAL PHARMACEUTICALS INC$2.5M +404.7%
  • COOPER COS INC$2.1M +491.0%
  • INSMED INC$2.1M +180.3%
Show all 31 →

Top Trims

  • IONIS PHARMACEUTICALS INC-$1.9M -66.6%
  • BIOMARIN PHARMACEUTICAL INC-$1.2M -43.8%
  • BELITE BIO INC-$648.1K -67.7%
  • PROTAGONIST THERAPEUTICS INC-$579.5K -58.9%
  • SELECT SECTOR SPDR TR-$491.6K -95.2%
Show all 10 →

New Positions

  • CITIGROUP INC$32.9M
  • GOLDMAN SACHS GROUP INC$31.3M
  • GLOBAL PMTS INC$27.9M
  • NORFOLK SOUTHN CORP$25.6M
  • AMERICAN ELEC PWR CO INC$25.4M
Show all 82 →

Exited Positions

  • ASE TECHNOLOGY HLDG CO LTD$3.9M
  • ASCENDIS PHARMA A/S$2.7M
  • PFIZER INC$2.0M
  • REGENERON PHARMACEUTICALS$1.9M
  • JOHNSON & JOHNSON$1.9M
Show all 35 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 VANECK ETF TRUST Call SMH 92189F676 $52.5M 11.43% 80,000 SH
2 CITIGROUP INC C 172967424 $32.9M 7.17% 235,033 SH
3 GOLDMAN SACHS GROUP INC GS 38141G104 $31.3M 6.82% 30,971 SH
4 STATE STR SPDR S&P 500 ETF T Call SPY 78462F103 $29.9M 6.51% 40,000 SH
5 GLOBAL PMTS INC GPN 37940X102 $27.9M 6.07% 384,114 SH
6 NORFOLK SOUTHN CORP NSC 655844108 $25.6M 5.57% 81,332 SH
7 AMERICAN ELEC PWR CO INC AEP 025537101 $25.4M 5.54% 185,962 SH
8 NVIDIA CORPORATION NVDA 67066G104 $25.1M 5.47% 125,539 SH
9 EXXON MOBIL CORP XOM 30231G102 $24.5M 5.34% 179,273 SH
10 ISHARES INC Put EWY 464286772 $17.3M 3.77% 86,000 SH
11 ALPHABET INC GOOGL 02079K305 $12.3M 2.69% 34,557 SH
12 ISHARES INC Put EWT 46434G772 $12.2M 2.65% 112,000 SH
13 MICRON TECHNOLOGY INC MU 595112103 $7.5M 1.64% 6,519 SH
14 ISHARES TR Call IGV 464287515 $7.2M 1.58% 80,000 SH
15 INTEL CORP INTC 458140100 $4.7M 1.02% 33,371 SH
16 SANDISK CORP SNDK 80004C200 $4.6M 0.99% 2,008 SH
17 ARGENX SE ARGX 04016X101 $4.1M 0.89% 4,392 SH
18 INFOSYS LTD INFY 456788108 $3.9M 0.84% 367,077 SH
19 CATERPILLAR INC CAT 149123101 $3.8M 0.82% 3,539 SH
20 AXSOME THERAPEUTICS INC. AXSM 05464T104 $3.4M 0.74% 13,831 SH
21 INSMED INC INSM 457669307 $3.2M 0.70% 30,170 SH
22 UNITEDHEALTH GROUP INC UNH 91324P102 $3.2M 0.69% 7,657 SH
23 BRUKER CORP BRKR 116794108 $3.2M 0.69% 52,780 SH
24 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $3.1M 0.69% 5,865 SH
25 TRAVERE THERAPEUTICS INC TVTX 89422G107 $3.1M 0.68% 55,112 SH
26 HUMANA INC HUM 444859102 $3.1M 0.68% 7,839 SH
27 ELI LILLY & CO LLY 532457108 $3.1M 0.67% 2,548 SH
28 REVVITY INC RVTY 714046109 $3.0M 0.66% 27,316 SH
29 PTC THERAPEUTICS INC PTCT 69366J200 $3.0M 0.66% 36,873 SH
30 ABBVIE INC ABBV 00287Y109 $3.0M 0.65% 11,928 SH
31 CHEMED CORP NEW CHE 16359R103 $3.0M 0.65% 6,365 SH
32 ISHARES TR SOXX 464287523 $2.9M 0.64% 4,590 SH
33 AGILENT TECHNOLOGIES INC A 00846U101 $2.9M 0.63% 21,826 SH
34 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $2.8M 0.61% 16,490 SH
35 TEVA PHARMACEUTICAL INDS LTD TEVA 881624209 $2.8M 0.61% 81,993 SH
36 ASTERA LABS INC ALAB 04626A103 $2.6M 0.56% 5,293 SH
37 COOPER COS INC COO 216648501 $2.5M 0.54% 34,743 SH
38 TWIST BIOSCIENCE CORP TWST 90184D100 $2.1M 0.45% 20,287 SH
39 QUALCOMM INC QCOM 747525103 $2.1M 0.45% 11,141 SH
40 ACADIA HEALTHCARE COMPANY IN ACHC 00404A109 $2.0M 0.43% 66,843 SH
41 DAVITA INC DVA 23918K108 $1.8M 0.39% 8,046 SH
42 ALNYLAM PHARMACEUTICALS INC ALNY 02043Q107 $1.7M 0.37% 5,588 SH
43 CONCENTRA GROUP HOLDINGS PAR CON 20603L102 $1.6M 0.34% 52,747 SH
44 BIOMARIN PHARMACEUTICAL INC BMRN 09061G101 $1.5M 0.34% 27,041 SH
45 BIOGEN INC BIIB 09062X103 $1.5M 0.32% 6,838 SH
46 OSCAR HEALTH INC OSCR 687793109 $1.5M 0.32% 51,105 SH
47 LAM RESEARCH CORP LRCX 512807306 $1.4M 0.30% 3,230 SH
48 SELECT SECTOR SPDR TR XLV 81369Y209 $1.4M 0.30% 8,600 SH
49 AVANTOR INC AVTR 05352A100 $1.3M 0.28% 131,088 SH
50 RAMBUS INC DEL RMBS 750917106 $1.3M 0.28% 9,559 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-13 $459.0M 129 0002032331-26-000012
2026-03-31 2026-05-14 $112.5M 82 0002032331-26-000010
2025-12-31 2026-02-11 $678.7M 104 0002032331-26-000001
2025-09-30 2025-11-14 $100.1M 79 0002032331-25-000011